Clinical Trials Browser

Not yet recruiting × OTHER × Injections × Clear all

NCT07480733 2026-03-18

A Phase II Clinical Study Evaluating the Safety, Tolerability,Pharmacokinetics, and Preliminary Efficacy of JS212 andJS213 as Monotherapy and in Combination in Patients Withadvanced Malignant Solid Tumors

Phase 2 Not yet recruiting

Other solid neoplasm

Advanced Malignant Solid Tumors

NCT07342322 2026-01-15

A Prospective, Multicenter, Open-label, Single-arm Phase II Clinical Study Evaluating the Efficacy and Safety of Spatially Fractionated Radiotherapy Combined With the PraG Strategy for the Treatment of Soft Tissue Sarcoma

Phase 2 Not yet recruiting

Sarcoma

NCT06951243 2025-04-30

A Trial of MHB088C in Advanced Extrapulmonary Neuroendocrine Cancer

Phase 2 Not yet recruiting

Advanced Extrapulmonary Neuroendocrine Cancer

NCT06939270 2025-04-22

CD73/AXL Targeted HypoSti.CAR-T Cells in CD73/AXL Positive Advanced/Metastatic Solid Tumors

Phase 1/2 Not yet recruiting

Hypoxia

NCT06809946 2025-02-20

Feasibility of Fluorescence Imaging with Bevacizumab-800CW During Bronchoscopy

Phase 1/2 Not yet recruiting

Lung Neoplasms

NCT06760520 2025-01-08

Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Locally Advanced Rectal Cancer

NCT06641453 2024-10-16

CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma

Phase 1/2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06508229 2024-07-18

Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06045767 2024-06-03

T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer

Phase 2 Not yet recruiting

Non-small Cell Lung Cancer Metastatic

NCT05996484 2023-08-21

Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT05821452 2023-04-20

Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma

Phase 2 Not yet recruiting

Chemotherapy

NCT05488353 2022-08-04

A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma

Phase 4 Not yet recruiting

Urinary Bladder Neoplasms